[{"id":"164b73e7-f269-49dd-b7cd-1661a8a687e1","acronym":"","url":"https://clinicaltrials.gov/study/NCT01675128","created_at":"2021-01-18T07:15:02.057Z","updated_at":"2024-07-02T16:37:32.540Z","phase":"Phase 1/2","brief_title":"ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer","source_id_and_acronym":"NCT01675128","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS wild-type • RAS wild-type","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS wild-type • RAS wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e irinotecan • ISIS-EIF4ERx"],"overall_status":"Completed","enrollment":" Enrollment 24","initiation":"Initiation: 08/01/2012","start_date":" 08/01/2012","primary_txt":" Primary completion: 12/01/2014","primary_completion_date":" 12/01/2014","study_txt":" Completion: 12/01/2015","study_completion_date":" 12/01/2015","last_update_posted":"2016-04-25"}]